Home » ETF » IBDR

IBDR - iShares iBonds Dec 2026 Term Corporate ETF

Stock Price: $26.47 USD -0.04 (-0.15%)
Updated Apr 16, 2021 4:00 PM EDT - Market closed
Assets $636.70M
NAV $26.31
Expense Ratio 0.10%
PE Ratio n/a
Beta (5Y) 0.17
Dividend (ttm) $0.66
Dividend Yield 2.52%
Ex-Dividend Date Apr 1, 2021
1-Year Return -
Trading Day April 16
Last Price $26.47
Previous Close $26.51
Change ($) -0.04
Change (%) -0.15%
Day's Open 26.49
Day's Range 26.46 - 26.50
Day's Volume 65,280
52-Week Range 24.68 - 26.98

Fund Description

The investment seeks to track the investment results of the Bloomberg Barclays December 2026 Maturity Corporate Index composed of U.S. dollar-denominated, investment-grade corporate bonds maturing in 2026. The fund generally will invest at least 90% of its assets in the component securities of the underlying index, and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index includes U.S. dollar-denominated, investment-grade securities publicly issued by U.S. and non-U.S. corporate issuers that have $300 million or more of outstanding face value at the time of inclusion.

Asset Class
Portfolio-Multi Asset
Sector
Income
Region
North America
Inception Date
Sep 13, 2016
Exchange
NYSEARCA
Ticker Symbol
IBDR
Index Tracked
Bloomberg Barclays December 2026 Maturity Corporate Index

Top 10 Holdings

8.02% of assets
NameSymbolWeight
Dell International L.L.C. and EMC Corporation 6.02%n/a1.16%
AbbVie Inc. 2.95%n/a0.93%
Microsoft Corporation 2.4%n/a0.83%
Wells Fargo & Company 3%n/a0.80%
Wells Fargo & Company 3%n/a0.78%
Oracle Corporation 2.65%n/a0.71%
Shire Acquisitions Investments Ireland DAC 3.2%n/a0.71%
JPMorgan Chase & Co. 2.95%n/a0.71%
Morgan Stanley 3.13%n/a0.70%
Apple Inc. 3.25%n/a0.70%
View All Holdings

Dividends

Ex-DividendAmountPay Date
Apr 1, 2021$0.05Apr 8, 2021
Mar 1, 2021$0.051Mar 5, 2021
Feb 1, 2021$0.052Feb 5, 2021
Dec 17, 2020$0.052Dec 23, 2020
Nov 2, 2020$0.055Nov 6, 2020
Oct 1, 2020$0.056Oct 7, 2020
Full Dividend History

News

There are no news available yet.